Call for abstracts

The call for abstract is now closed.

Alzheimer Europe, Alzheimer Schweiz Suisse Svizzera and Alzheimer Genève would like to thank all submitters. We have received a record number of 577 abstracts for oral and poster presentations.

Results will be announced on 15 June. 

Innovation in care and research

  1. Artificial intelligence
  2. Assistive technologies
  3. Dementia registries
  4. Preparing for new AD treatments
  5. Telehealth and remote care
  6. Clinical trial recruitment and retention

Living with dementia

  1. People living with dementia
  2. Housing and neighbourhoods
  3. Art and dementia
  4. Empowerment and self-management
  5. Relationships and sexuality
  6. Stigma and discrimination

Patient pathways

  1. Brain health and prevention
  2. Detection and diagnosis
  3. Treatment and medical management
  4. Psycho-social interventions
  5. Hospital Care
  6. End-of-life care

Inclusion and intersectionality

  1. Gender
  2. Minority ethnic groups
  3. LGBTQ+
  4. Intellectual disability and Down syndrome
  5. Public involvement in dementia research
  6. Young onset dementia

Policy

  1. Dementia strategies
  2. New funding models for dementia care and research
  3. Legal and ethical issues
  4. National Alzheimer's associations
  5. Campaigning for change
  6. Dementia work force

 

Abstract Guidelines

Guidelines for writing abstracts

Please respect the following guidelines when writing your abstract:

  • Only abstracts submitted in English will be considered. 
  • Abstracts need to be submitted via the online submission system. Abstracts submitted by e-mail, fax or post will be ignored.
  • Abstracts should be written in concise form and should not exceed 300 words.
  • Abstracts need to be submitted following the online template guidelines.
  • Please make sure to use a non-discriminatory language when referring to people with dementia. The terms “person with dementia” or “people with dementia “ should therefore be used rather than “victims”, “sufferers”, the “demented” or “dementing” or other stigmatising language. (see our guidelines for Ethical and inclusive communication)
  • As AE Conferences are open to a lay audience, presentations on licensed medicines, whether promotional in nature or not, will not be accepted. The use of trade marked names is similarly not allowed.
  • Abstracts should be clearly linked to one of the topics of the call for abstracts. You will be asked to choose a specific topic when submitting your abstract.

Guidelines for submitting abstracts

  • Alzheimer Europe will accept submission of abstracts for oral, quick oral or poster presentations.
  • Please note that oral presentations will be for 10-12 minutes followed by 3 to 5 minutes of questions.
  • Quick oral presentations shall not exceed 5 minutes.
  • All abstracts must be submitted by 15 May at the latest.
  • You will receive an e-mail notification after submitting your abstract. If you have not received an e-mail notification after submitting your abstract, please contact the Alzheimer Europe secretariat.

Evaluation of abstracts

  • All abstracts will be evaluated by the Programme Committee.
  • For each topic, a minimum of 3 or 4 members of the Programme Committee will rate each abstract which will have been anonymised prior to evaluation.

For abstracts submitted for oral presentations, the following procedure will apply:

  • The five highest rated abstracts for each topic will be selected as oral presentations for inclusion in the final programme.
  • Only one abstract per author will be accepted for inclusion as an oral presentation. If more than one abstract qualifies, only the highest rated abstract will be included in the final programme. Additional abstracts by the same author may be accepted as quick oral or poster presentations.
  • Abstracts that have not been accepted for oral presentation can be selected for quick oral or poster presentation, as long as they reach the required threshold average mark.
  • Abstracts that have not reached the required average mark will be rejected.

For abstracts submitted for poster presentation only, the following procedure will apply:

  • Abstracts that have reached the required threshold average mark will be accepted.
  • All other abstracts will be rejected.

Acceptance of abstracts

  • All authors will be informed about the decision of the Programme Committee by 15 June 2024.
  • If accepted, only minor changes to the submitted abstract will be permitted. It is the author’s responsibility to ensure that abstracts are correct in terms of accuracy of contents, spelling and grammar.
  • All presenters need to register for the conference by the early bird registration deadline of 15 July 2024. Past this date the presentation will be removed from the programme and replaced with the next best graded abstract.
  • All oral and poster presenters need to present in-person at the event in Geneva.

 

Acknowledgement
Alzheimer Europe, Alzheimer Schweiz Suisse Svizzera and Alzheimer Genève gratefully acknowledge the support of all conference sponsors.
Image